RecruitingNot ApplicableNCT05525039

RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myosteatosis and NMJ Degeneration

Dissecting the Therapeutic Mechanism of an Effective Combination Treatment Targeting Neuromuscular Junction Dengeneration and Myosteatosis to Combat Sarcopenia


Sponsor

Chinese University of Hong Kong

Enrollment

200 participants

Start Date

Jan 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators' pre-clinical study confirms the positive effects of combined treatment (VT + HMB) on reducing fat-to-lean tissue ratio, intramuscular fat infiltration and increasing muscle strength in sarcopenia animal model. The results showed that fat mass could be decreased by \~32%, while histology Oil Red O staining indicated a decrease of fat by almost 60%; in contrast, lean muscle mass increased by \~14%. On muscle strength, combined treatment increased twitch force, tetanic force and grip strength by \~30-66%. These in vivo results are very encouraging and the investigators should explore its potential in clinical translation. As VT and HMB supplement have been commercially available and their compliance rates are satisfactory, they can be translated to clinical application easily. The investigators' next step is to confirm its clinical efficacy, so that sarcopenia becomes a new indication of VT and HMB. The hypothesis is that combined treatment of VT and HMB can retard the progression of sarcopenia in human, in terms of muscle mass, muscle strength and performance.


Eligibility

Min Age: 60 Years

Inclusion Criteria5

  • Subjects aged 60 years or above
  • Subjects failed in AWGS algorithm
  • skeletal muscle mass by BIA (male at \<7.0 kg/m\^2, female at \<5.7 kg/m\^2), and
  • handgrip strength (male at \<28 kg, female at \<18kg), and/or
  • gait speed test (\>1m/s)

Exclusion Criteria8

  • Subjects with pathological bone diseases
  • Subjects with chronic inflammatory condition (e.g. rheumatoid arthritis)
  • Subjects with neurological problems
  • Subjects receiving regular exercise
  • Subjecs who are chair-/bed- bound
  • Subjects with malignancy
  • Subjects with cardiovascular concern such as with pace-maker in-situ
  • Subjects with acute fractures or severe osteoarthritis

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELow-magnitude High-frequency Vibration

0.3g, 35Hz, 20mins/day, at least 3 times/week

DIETARY_SUPPLEMENTβ-hydroxy β-methylbutyrate (HMB) supplement

Oral nutritional HMB supplement at 3g/day

DIETARY_SUPPLEMENTProtein supplement

Daily protein supplement intake


Locations(3)

Evangelical Luthera Church Social Service - Hong Kong

Hong Kong, Hong Kong

The Chinese University of Hong Kong Jockey Club Centre for Osteoporosis Care and Control

Hong Kong, Hong Kong

The Chinese University of Hong Kong, Department of Orthopaedics and Traumatology, 1/F Li Ka Shing Outpatient Clinic (North), PWH

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05525039


Related Trials